Highlights,Acquisition Deal Finalized:,Tempus AI acquired,Ambry Genetics,for,$600 million,in cash and stock.,Strategic ...

A good GPU in your rig can make all the difference while gaming, but their prices can often be out of reach, making the best cheap graphics card an even more essential item in the PC components ...

Comparing the Xbox Series X versus Series S all comes down to graphics since they can both play the best Xbox Series X games. Despite having an uneven release schedule from first-party studios ...

The best graphics cards for video editing can make a huge difference to the speed of your workflow. They play a vital role in allowing your computer to cope with the graphical demands of VFX, ...

Intel's Arc B580 graphics cards have been its best-reviewed to date, maintaining the aggressive pricing of the old A-series Arc cards with fewer driver bugs, fewer weird performance outliers ...

Tempus AI is a leading player in healthcare AI, aiming to deliver personalized treatment suggestions through its proprietary data model. Preliminary Q4 results and 2025 guidance show mixed ...

Ahead of the pending launch of its new RTX 50-series graphics cards. Nvidia released a flood of new details about its GPU architecture and the AI features that will bolster it. Here's a rundown of ...

The OmniStudio X is based on Core Ultra CPUs from Intel's Meteor Lake family of AI processors, and our test system features a GPU upgrade that lends some 3D gaming and graphics capabilities.

Precision medicine company Tempus AI, which uses artificial intelligence to process medical data, announced this week new capabilities within its generative AI assistant. Tempus One, which ...

Analysts' ratings for Tempus AI TEM over the last quarter vary from bullish to bearish, as provided by 6 analysts. The following table encapsulates their recent ratings, offering a glimpse into ...

Tuesday, Tempus AI Inc (NASDAQ:TEM) shares were in focus after Loop Capital adjusted its price target on the company. Analysts at Loop Capital trimmed the price target to $52.00 from $57.00 ...

AI medicine company Tempus released a peak at its 2024 financials during yesterday's J.P. Morgan Healthcare Conference, saying its revenue of about $693 million showed 30% growth year over year ...